SB-743921
SB 743921 is a drug used to treat Hodgkin's Disease, Non-Hodgkin's Lymphoma, and Solid Tumor Cancer. SB 743921 is not being actively studied and prior, has been studied in 2.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Cytokinetics | Cornell University Medical Center | |
| GlaxoSmithKline | GSK Investigational Site | |
| Hackensack University Medical Center |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
- SB-743921
- Hackensack, New Jersey
- +7 more
2020-01-09
Jan 9, 2020G
Completed
- Solid Tumor Cancer
- SB-743921
- Pittsburgh, Pennsylvania
- +1 more
2008-10-15
Oct 15, 2008